Examination Report |
1 | TM-A(TRADE MARKS APPLICATION) | 11 Feb 2021 |
2 | Reply to Exam Report (MIS-R) | 05 Mar 2021 |
3 | TM-M(CORRECTION OF CLERICAL ERROR OR FOR AMENDMENT U/R 37) | 16 Mar 2022 |
4 | TM-O(NOTICE OF OPPOSITION) | 14 May 2024 |
5 | Journal Copy | 22 May 2024 |
1 | EXAMINATION REPORT | 11134827 | 18 Feb 2021 | |
2 | Hearing Notice (Show Cause) | 14288755 | 02 Nov 2022 | |
3 | Hearing Notice (Show Cause) | 15612103 | 14 Jul 2023 | |
4 | Hearing Notice (Show Cause) | 16511019 | 09 Nov 2023 | |
5 | Tribunal Accepted Notice for : 4859199 | 17007333 | 6428714 | 02 Jan 2024 |
The application for Luzumac was made on 11 February 2021.
The trademark applicant for Luzumac is CUREVER PHARMA.
Luzumac is applied in class(es) 5.
Application for Luzumac is on Opposed stage.
Application Id allotted to Luzumac is 4859199.
Trademark agent or attorney for the application is Vishesh And Associates.
Luzumac filed with the Intellectual property office as a WORD.